InTandem Capital Partners is launching Vivo Infusion, a new network of ambulatory infusion centers (AIC) created via the firm’s simultaneous investments in MPP Infusion Centers and ID Consultants.
Why it matters: With patient demand for infusion and injection care expanding — and the supply of available therapies on this front also growing — more cost-effective, quality providers are needed, InTandem senior managing director Brad Coppens tells Axios.